| Mrs Geraldine Romero, ADN | |
|
2450 Alamo Se, Albuqerque, NM 87106 | |
| (505) 925-2400 | |
| Not Available |
| Full Name | Mrs Geraldine Romero |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Addiction (substance Use Disorder) |
| Location | 2450 Alamo Se, Albuqerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568717585 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | R51744 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Geraldine Romero, ADN 10727 Mcmichael Ln Sw, Albuquerque, NM 87121-3644 Ph: (505) 429-7920 | Mrs Geraldine Romero, ADN 2450 Alamo Se, Albuqerque, NM 87106 Ph: (505) 925-2400 |
News Archive
A collaboration of researchers, led by Dr. Martine Roussel of St. Jude Children's Research Hospital, has developed a novel mouse model of medulloblastoma - the most prevalent malignant pediatric brain tumor - that the researchers hope will more accurately represent the genetic changes involved in human brain tumor development.
The perception that antibiotic resistance is primarily the undesirable consequence of antibiotic abuse or misuse is a view that is simplistic and inaccurate, according to a recent report by the American Academy of Microbiology. The reasons behind the spread of resistance are much more complex, including appropriate antibiotic use, lack of proper sanitation and hygiene, and even the environment.
Many people with developmental disability are sedentary and obese, have poor diet, and consequently suffer from conditions such as cardiovascular disease, osteoporosis, hypertension and type 2 diabetes. Promoting healthy lifestyles for this group is the aim of a new project that teams University of Illinois at Chicago researchers with two community-based nonprofit organizations in Albuquerque, N.M. and suburban Chicago.
Researchers have found that, contrary to prvious clinical trial findings, monthly injections to counteract age-related macular degeneration (AMD) may not be necessary.
In low-risk pregnant women, high induction and first-cesarean delivery rates do not lead to improved outcomes for newborns, according to new research published in the April issue of The Journal of Maternal-Fetal and Neonatal Medicine.
› Verified 9 days ago